Precision Repair for High-Risk Patients: The NovoClasp Transcatheter Mitral Valve Clip System from Enlight Medical Is Approved by NMPA
The NovoClasp Transcatheter Mitral Valve Clip System is a breakthrough device that offers a life-changing, minimally invasive alternative for patients suffering from severe degenerative mitral...
ConBrella® Biodegradable PFO Occluder Approved by NMPA
ConBrella® Biodegradable Patent Foramen Ovale (PFO) Occluder System manufactured by Wuyou Tiaodong (WYTD) Medical Technology (Shenzhen) Co., Ltd. is officially approved by NMPA to launch...
Filling the Gap for High-Risk Patients: PIONEER TAVR® Transcatheter Aortic Valve System Approved by NMPA
Product Overview This innovative system from KOKA Lifesciences focuses on the precise clinical needs of elderly, high-risk patients suffering from symptomatic, severe aortic valve insufficiency...
Breakthrough in Precision Cardiac Access: RF-cross® Radiofrequency Transseptal Needle
Product Overview The RF-cross® is China’s first transseptal puncture system to integrate “Zero-Exchange” workflow, mechanical + radiofrequency (RF) dual technology, and steerable sheath compatibility. It...
Approval of the EasyEcho™ Intracardiac Echocardiography Imaging Catheter
On January 29, the National Medical Products Administration (NMPA) granted marketing approval to Shanghai MicroPort EP MedTech Co., Ltd. for the EasyEcho™ disposable intracardiac echocardiography...
SceneRay Receives NMPA Approval for World-First DBS System Targeting Opioid Addiction
In a landmark development for the global neuromodulation market, the National Medical Products Administration (NMPA) has officially granted marketing approval to SceneRay Medical’s Implantable Deep...
PerMedos’s Branched Intraoperative Aortic Stent System – A New Era for Stanford Type A Dissection Treatment Obtained NMPA Approval
The National Medical Products Administration (NMPA) of China approved the launch of the innovative product, the Helix Branched Intraoperative Aortic Stent System from PerMedos on...
The Evolution of Spinal MedTech in China: Strategic Implications for International Stakeholders
November 21, 2025 The technological trajectory of spinal minimally invasive surgery (MIS) and interventional techniques is globally trending toward increased precision, intelligence, reduced invasiveness, and...
China’s First: Meio Cardinav Medical’s Innovative Cardiac Electrophysiology Interventional Surgery Control System “TITIAN” Approved for Market Launch
November 14, 2025 On October 31st, the Cardiac Electrophysiology Interventional Surgery Control System, branded as “TITIAN” developed by Meio Cardinav Medical, received market approval from...
The 1st Domestically Developed Invasive BCI Device Got Approved in China
“Mingtong (明瞳）,” a functional neurosurgical electrophysiological recording and stimulation device, has been officially approved for market release by China’s National Medical Products Administration (NMPA). Developed...